Short video interview but well worth watching. Mentioned that...

Short video interview but well worth watching. Mentioned that Siemens are still collaborating with IBX, the next set of trials ( after the 2nd cohort trials are concluded here in Oz) will need to be larger ( 200 patients possibly was mentioned) and to be undertaken in the USA and maybe partly in Europe as well.
My personal guess is things will progress faster in the USA/Europe than here in Oz.. its a numbers game and the population centres are there. I suspect also less reticence to participate in trials. Good to see Siemens are still collaborating and testing parameters are being progressively refined..... would not surprise me if Siemens would want a seat at the table and assist with financing the larger trial, its my guess only, but makes sense. Obviously we dont have the finances to support such a large trial, a CR at prevailing share price would seem nonsensical, better to have a big pharma "sugar daddy" on-board for financing/equity stake